Saluda Medical spinal cord stimulator approved by FDA

Saluda Medical’s Evoke spinal cord stimulator received FDA approval for treating chronic intractable pain, the devicemaker said in a March 8 news release.

Advertisement

Evolve is a closed-loop system designed for pain in the trunk and/or limbs. It’s the first available spinal cord stimulator that can instantaneously read, record and respond to evoked compound action potentials, according to the release.

Saluda Medical plans a limited release of Evoke in the second half of 2022 and a full commercial launch in 2023.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.